The European Society of Cardiology Released the New Guidelines for the Management of Stable Coronary Artery Disease Patients......

Today, September 1, 2013, at 16h30 Amsterdam time, the European Society of Cardiology released the new guidelines for the Management of Stable Coronary Artery Disease patients recognizing ivabradine (CORALAN) as "an effective Anti-Anginal Agent, Alone or Combination with B-blockers".
 
Adding ivabradine (CORALAN) 7,5 mg twice daily to β-blockers (atenolol) gives better control of heart rate and angina symptoms.
 
 
Author
Florent DARCHEZ
 
Source
ESC guidelines 2013